RESUMO
The inhalation treatment of silicosis with polyvinyl-pyridine-oxide of molecule weight about 90,000 under the name Kexiping is the most perspective method at the moment for etiological effect of the silicotic fibrosis. The authors performed two 6-week inhalation course with interval of 6 months with 38 ill with silicosis. The daily dose 10 ml of 4% solution of Kexiping "Bayer". The first results alone and in comparison with the control group of 50 patients are very encouraging. The tolerance to the preparation is excellent, with no side effects or unfavourable deviations in the paraclinical indices. Further extensive, therapeutic applications and inhalation prophylaxis with healthy persons subject to high dust risk are completely justified. For final evaluation of the long-term effect a continuous observation of both treated and controls is necessary.
